Drawing for KYOWA KIRIN

USPTO serial 79157157

KYOWA KIRIN

Reviewed by CopyMark Law Group

Reg. 4853214Status 404
Filing date
Status date
Registration date
Nov 17, 2015
Examiner
LAW, CHRISTOPHER M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KYOWA KIRIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Lim

Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42nd St., 17 Fl.NEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical machines and apparatus, namely, apparatus for blood analysis, devices for measuring blood sugar, apparatus for analyzing chemicals for medical purposes, apparatus for analyzing drugs and drug metabolites, inhalers for medical purposes, defibrillators, medical apparatus for treating respiratory conditions, infusion devise for administering drugs, infusion pumps for delivering measured amounts of solutions into the bloodstream over time, blood component separation apparatus for medical purposes, medical apparatus for treating cardiovascular disease, medical devices for treating sleep disorders; diagnostic apparatus for medical purposes, namely, apparatus for analyzing body fluids, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing, diagnostic apparatus for detecting infection and for detecting the disease state of human illnesses; apparatus for analysis of biological materials for medical purposes; injection devices for pharmaceuticals; injection needles for medical purposes; blood transfusion apparatus or devices; infusion apparatus or devices for therapeutic purposes, namely, infusion and injection devices for administering drugs, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; medical tubing or tubing connectors for use in dialysis machines or dialysis treatmentSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 8, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 8, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 23, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 1, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 1, 2023INPCINVALIDATION PROCESSED—
Feb 3, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 3, 2022C71TCANCELLED SECTION 71—
Jun 1, 2021BDFUBIRTH/DEATH MERGER PROCESSED BY USPTO—
Nov 17, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 8, 2020CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Dec 10, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 11, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 2, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jun 2, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 19, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 17, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 30, 2015DCPNCHANGE OF OWNER RECEIVED FROM IB—
Sep 25, 2015GPNXNOTIFICATION PROCESSED BY IB—
Sep 1, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 1, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 12, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 12, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 12, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 31, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 28, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 22, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 22, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 22, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 15, 2015ALIEASSIGNED TO LIE—
Jul 8, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 30, 2015RFNTREFUSAL PROCESSED BY IB—
Jan 9, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 9, 2015RFRRREFUSAL PROCESSED BY MPU—
Jan 5, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 4, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 23, 2014DOCKASSIGNED TO EXAMINER—
Dec 23, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 18, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance